The Full Story
SYNAPTICA VENTURES
Synaptica Ventures, founded by renowned neuroscientist, innovator and serial entrepreneur Roy Cohen, is a private neuroscience research lab focused on fostering rapid innovation to address mental health, psychiatric, and general health challenges. By emphasizing creative, out-of-the-box thinking, the team consistently challenges conventional industry norms to pioneer novel solutions. Their unique approach combines cutting-edge research with agile venture development, creating an environment that accelerates the path from discovery to impactful implementation. Synaptica Ventures is committed to challenging the status quo, reimagining possibilities, and advancing health science in unconventional ways.
Barbara
Barbara is a virtual therapist designed to enhance emotional control using a scientifically grounded approach. She combines emotional reflection with cognitive exercises, specifically simple math tasks, to engage the prefrontal cortex and promote logical thinking. This technique shifts focus from emotional processing to problem-solving, helping users gain perspective over overwhelming emotions while enhancing stress and anxiety management skills. A daily five-minute session with Barbara fosters emotional reflection and cognitive improvement, empowering users to develop better emotional control through this innovative, science-based method.
Serodop Theory
We are excited to introduce a groundbreaking new framework for understanding and treating mental health disorders based on neurobiological principles. Our innovative approach incorporates a two-axis map that integrates dopaminergic and serotonergic systems, offering a more nuanced understanding of the neurochemical underpinnings of psychiatric conditions. By differentiating between dopamine-driven reward processing and serotonin-mediated inhibition, this framework holds immense promise for personalized treatment strategies and improved therapeutic outcomes. We invite researchers passionate about advancing mental health research to join us in exploring this transformative approach. Together, we can pave the way for innovative treatments that address the complex interplay of neurotransmitter systems and enhance the well-being of individuals worldwide. Reach out to us to learn more and become part of this exciting journey toward revolutionizing mental health care!
